Zacks Small Cap Analysis – IMNN: Translational Knowledge from OVATION 2 Offered… – Model Slux
By David Bautz, PhD NASDAQ:IMNN READ THE FULL IMNN RESEARCH REPORT Enterprise Replace OVATION 2 Translational Knowledge Offered at ESMO On June 18, 2025, Imunon, Inc. (NASDAQ:IMNN) introduced the presentation of translational information from the OVATION 2 medical trial of IMNN-001 on the European Society for Medical Oncology (ESMO) Gynaecological Cancers Congress 2025. These outcomes … Read more